The Prevalence of Behçet's Disease in a Thrombosis Clinic.
Behçet’s disease
prevalence
thrombosis clinic
Journal
Mediterranean journal of rheumatology
ISSN: 2529-198X
Titre abrégé: Mediterr J Rheumatol
Pays: Greece
ID NLM: 101730166
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
21
12
2021
accepted:
15
01
2022
medline:
24
5
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
epublish
Résumé
the prevalence of venous thromboembolism (VTE) in Behcet's disease (BD) is around 40%, though recognition of BD in a thrombosis clinic has been poorly addressed. to evaluate the prevalence of signs and symptoms leading to the diagnosis of BD in a thrombosis clinic compared to patients attending a general haematology clinic and to healthy controls. Design: cross-sectional case-double control anonymous questionnaire survey. Participants: consecutive patients with spontaneous VTE (n=97) attending a thrombosis clinic, consecutive patients from a general haematology (GH) clinic (n=89) and controls (CTR). BD was diagnosed in 1.03% of VTE participants, in 2.2% of GH participants and in 1.2% of healthy CTR. Exhaustion was more common reported in participants from the VTE group (15.6%) than in those from the GH group (10.3%) and from the healthy CTR (3%) (p=0.06); the sum of signs and symptoms of BD clustered in the VTE group (89.5%) compared to the GH (72.4%) and the CTR (59.7%) (p<0.0001). BD may be diagnosed in 1 every 100 patients with VTE attending a thrombosis clinic and in 2 every 100 patients attending a GH clinic: awareness must be raised not to under-diagnose or misdiagnose BD in these settings as management of VTE in BD deviates from the norm.
Sections du résumé
Background
UNASSIGNED
the prevalence of venous thromboembolism (VTE) in Behcet's disease (BD) is around 40%, though recognition of BD in a thrombosis clinic has been poorly addressed.
Objective
UNASSIGNED
to evaluate the prevalence of signs and symptoms leading to the diagnosis of BD in a thrombosis clinic compared to patients attending a general haematology clinic and to healthy controls. Design: cross-sectional case-double control anonymous questionnaire survey. Participants: consecutive patients with spontaneous VTE (n=97) attending a thrombosis clinic, consecutive patients from a general haematology (GH) clinic (n=89) and controls (CTR).
Results
UNASSIGNED
BD was diagnosed in 1.03% of VTE participants, in 2.2% of GH participants and in 1.2% of healthy CTR. Exhaustion was more common reported in participants from the VTE group (15.6%) than in those from the GH group (10.3%) and from the healthy CTR (3%) (p=0.06); the sum of signs and symptoms of BD clustered in the VTE group (89.5%) compared to the GH (72.4%) and the CTR (59.7%) (p<0.0001).
Conclusions
UNASSIGNED
BD may be diagnosed in 1 every 100 patients with VTE attending a thrombosis clinic and in 2 every 100 patients attending a GH clinic: awareness must be raised not to under-diagnose or misdiagnose BD in these settings as management of VTE in BD deviates from the norm.
Identifiants
pubmed: 37223605
doi: 10.31138/mjr.34.1.66
pii: MJR-34-1-66
pmc: PMC10201090
doi:
Types de publication
Journal Article
Langues
eng
Pagination
66-70Informations de copyright
© 2023 The Mediterranean Journal of Rheumatology (MJR).
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Adv Exp Med Biol. 2003;528:95-7
pubmed: 12918670
J Eur Acad Dermatol Venereol. 2001 Mar;15(2):126-36
pubmed: 11495519
Rev Med Interne. 2014 Feb;35(2):103-11
pubmed: 24434015
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Adv Exp Med Biol. 2017;906:363-375
pubmed: 27628001
Thromb Haemost. 2009 Dec;102(6):1219-26
pubmed: 19967154
Int J Dermatol. 2006 Aug;45(8):919-21
pubmed: 16911374
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47
pubmed: 23441863
Semin Arthritis Rheum. 1998 Feb;27(4):197-217
pubmed: 9514126
Arthritis Rheum. 2008 Dec;58(12):3951-9
pubmed: 19035493
Rheumatology (Oxford). 2001 Jun;40(6):652-5
pubmed: 11426022
Arthritis Rheum. 2012 Aug;64(8):2753-60
pubmed: 22354392